A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
A case report of daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) as an adjunctive treatment for Alzheimer disease
2012
Brain Stimulation
Alzheimer's disease (AD) is the most common type of dementia. Current medication treatment is based on two main groups: anticholinesterases (IAChE) and NMDA receptor antagonists. These medications have demonstrated a symptomatic effect on certain cognitive and noncognitive symptoms of AD in the short term (6 months in most studies), although these effects are only limited. 1,2 With diagnostic tools for AD becoming increasingly sophisticated, the pathology is identified at earlier stages than
doi:10.1016/j.brs.2011.03.003
pmid:22037125
fatcat:3oxprddribfopmpk4llt5jgh3y